Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RBCPF in mild to moderate anemia
NCT01701531Phase 3Withdrawn
- Sponsor
- Targeted Medical Pharma, Inc.
- Start
- Oct 2012
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of RBCPF in anemia, sponsored by Targeted Medical Pharma, Inc.. Planned start Oct 2012; status: withdrawn.
02
Drugs
RBCPF
03
Conditions
anemia
Beyond the preview
Go deeper on NCT01701531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01701531.